Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PHOENIX, Oct. 23, 2018 (GLOBE NEWSWIRE) -- Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is a drug delivery platform innovator that has developed and out-licenses...
-
Phoenix, March 12, 2018 (GLOBE NEWSWIRE) -- Phoenix, AZ – March 13, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, today...
-
Phoenix, AZ, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire is the sole producer of the Uptick Network “Stock Day” Podcast and after airing back in January 2016 CEO and host Everett Jolly has...
-
KELOWNA, British Columbia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, announces it has filed a...
-
KELOWNA, British Columbia, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, announces it has...
-
KELOWNA, BC--(Marketwired - August 31, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (CSE: LXX.CN) (CNSX: LXX) (the "Company" or "Lexaria") announces the world's first clinical study on...
-
Kelowna, BC , Aug. 10, 2017 (GLOBE NEWSWIRE) -- CEO Chris Bunka was Interviewed on Uptick Network Discussing Company’s Positive Future Progress Kelowna, BC (UPTICK Newswire – August 10, 2017) -...
-
KELOWNA, BC--(Marketwired - July 20, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (CSE: LXX.CN) (CNSX: LXX) (the "Company" or "Lexaria") announces the start of laboratory work under its...
-
KELOWNA, BC--(Marketwired - July 18, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") is pleased to announce that the Australian Patent Office has granted patent...
-
VANCOUVER, BC--(Marketwired - June 22, 2017) - Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces the filing of a new provisional patent application and stock...